³Ô¹ÏÍøÕ¾

Latest biotech News | Page 19

Novartis signs US$50 million commercial deal with Australian biotech firm
Three TU/e startups among best academic startups of 2020
Andrew Zydney virtually visits University of Alabama
A new vaccine facility for Melbourne
University of Oxford/AstraZeneca Vaccine Candidate
CSL Named as One of World’s Best Employers
CSL’s Annual Research and Development Day Briefing
2021 CSL Centenary Fellowships Announced
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine
Four TU/e startups competing to become ‘Best academic start-up in Netherlands’
Joy Linton named as Chief Financial Officer
Clinical trial boom for Victorian biotech firms
ALSA Ventures Closes US$59 Million European Biotech Venture Capital Fund
Industry Excellence Awards to celebrate greatest sector responses to pandemic
Urgent call for older Queenslanders to volunteer for COVID-19 study
CSL statement on COVID19 Vaccine Manufacture
At White House Roundtable, Paul Perreault Urges People to Donate Plasma in Fight Against COVID-19
Insight – Fast-track approvals in China’s drugs market to unlock pharma prospects
$600,000 federal grant for quick 30 minute COVID-19 test
Inaccurate Report of COVID-19 Vaccine Agreement
Rare Diseases in Asia-Pacific
UQ COVID 19 Vaccine to Commence Human Trials
CSLBehring Gene Therapy Agreement with uniQure
David Lamont appointed Chief Financial Officer
Monash University announces research collaboration with Janssen to tackle coeliac disease
Bringing buildings back to life in a COVID-19 World
Stoic Venture Capital increases funds for university start-ups amidst widespread withdrawal 12 June
Stoic Venture Capital increases funds for university start-ups amidst widespread withdrawal
UQ, CEPI and CSL partner for COVID-19
Miracle cures and fast-track approval threatens medical advances, say scientists
2021 CSL Centenary Fellowships
Joint industry statement: Industry unites in call to back our biotechs to keep jobs during COVID-19
Development of COVID-19 immunoglobulin commences
CSL Behring and SAB Biotherapeutics Join Forces
Collaborating on Potential COVID-19 Therapy
CSL’s Global Role in Battling COVID-19
Clinical trials are critical in COVID-19 fight
Griffith signs MOU with Bio manufacturer to chase COVID-19 vaccine
Government lacks ambition to make NZ predator free
Women in life sciences celebration draws more than 440 leaders
New chemo combo shows promise versus pancreatic cancer
Victoria Lands Trial Of Direct Flights To Israel
CSL statement on Coronavirus
CSL Ranks Among Best Employers for Diversity
Biotech to be harder hit
Biotech industry astonished as government moves on plan to cut R&D incentive
CSL Continues to Advance R&D Capabilities
Cash prize awarded to early-stage biotech project